Pro Investor on eToro 🟢 Occasionally I swing trade & occasionally that works out 👀
My live tracker 👇
Joined August 2026
- Tweets3.6K
- Following150
- Followers1.1K
- Likes9.6K
Pinned Tweet
New here? Start with this 📌
I share free swing setups on US stocks, and every one goes on my public tracker:
mohanadinv.grok.me (also in my bio)
Every setup has a Confirm level, an Invalid level and up to 3 targets. The tracker follows each one from the day I post it.
What you can do there:
Filter by status: still valid, hit a target, exited or invalid
Filter by pattern: triangles, flags, wedges, cups, breakouts
Sort by newest, best close or highest peak
See the high each stock reached after I posted it
📊 Wins and losses stay up. Nothing gets deleted.
🟢 Average gain on winners: 20.1%
🔴 Average stop loss: down 6.2%
There's also an Investment ideas tab for my longer term plans.
Drop a ticker below and I'll check it for a pattern 👇
Mohanad Yaman retweeted
Can we just get him to 2k
Thanks. Hes providing some of the best alpha on this app.
GET @MohanadInv TO 2K TODAY 🔥
New here? Start with this 📌
I share free swing setups on US stocks, and every one goes on my public tracker:
mohanadinv.grok.me (also in my bio)
Every setup has a Confirm level, an Invalid level and up to 3 targets. The tracker follows each one from the day I post it.
What you can do there:
Filter by status: still valid, hit a target, exited or invalid
Filter by pattern: triangles, flags, wedges, cups, breakouts
Sort by newest, best close or highest peak
See the high each stock reached after I posted it
📊 Wins and losses stay up. Nothing gets deleted.
🟢 Average gain on winners: 20.1%
🔴 Average stop loss: down 6.2%
There's also an Investment ideas tab for my longer term plans.
Drop a ticker below and I'll check it for a pattern 👇
$INTC almost quadrupled in six months. Then it gave back 35.65% 📉
Still up 145.80% this year.
Intel started 2026 at $36.90, ran all the way to $140.94 in June, and trades at $90.70 today.
🔴 Last time it reported, it fell 7.89% the next day. It reports again Thursday.
Is this a healthy pullback or the end of the run?
$LTH TP1 hit in less than 2 hours ✅
Confirmed at 41.93 on Friday, posted yesterday, and touched 44.17 today, up 5.3%.
Next up are TP2 at 47.24 and TP3 at 50.16. Q3 results come Thursday before the open, so expect a big move either way 📊
$LTH triangle is breaking out 👀
Life Time, premium athletic country clubs across the US and Canada.
🔹 Higher lows from $36.52 while sellers kept capping it at $41.73
🔹 Friday closed at $41.93, just over the lid
🔹 The next hurdle is Friday's high at $42.58
📊 Q2 revenue $866.0M (+13.7%) vs about $845M expected, adjusted EBITDA $246.5M (+16.8%) at a 28.5% margin
💰 FY26 guide raised: revenue $3.35–$3.375B, adjusted EBITDA $940–$955M, comparable center revenue +7.9–8.3%
📈 Net debt leverage improved to 1.4x from 1.8x, and S&P and Fitch both upgraded to BB
⚠️ Positive free cash flow depends on a $400M sale-leaseback target ($200M done in Q2), and Q3 results come Thursday, Oct 29 before the open
✅ Confirm: daily close holds over $41.93
🟢 TP1 $43.96 (+4.8%) • TP2 $47.24 (+12.7%) • TP3 $50.16 (+19.6%)
⛔ Invalid: daily close under $41.10 (−2.0%)
Risk from the Confirm level to Invalid is about 2.0%, and TP1 pays about 2.4x.
Please respect your SL level 🙏
Mohanad Yaman retweeted
New here? Start with this 📌
I share free swing setups on US stocks, and every one goes on my public tracker:
mohanadinv.grok.me (also in my bio)
Every setup has a Confirm level, an Invalid level and up to 3 targets. The tracker follows each one from the day I post it.
What you can do there:
Filter by status: still valid, hit a target, exited or invalid
Filter by pattern: triangles, flags, wedges, cups, breakouts
Sort by newest, best close or highest peak
See the high each stock reached after I posted it
📊 Wins and losses stay up. Nothing gets deleted.
🟢 Average gain on winners: 20.1%
🔴 Average stop loss: down 6.2%
There's also an Investment ideas tab for my longer term plans.
Drop a ticker below and I'll check it for a pattern 👇
Mohanad Yaman retweeted
Buy or Bye? 🤔 $MRK
Merck ran up 77% from its 52 week low of $82.01 and now sits 7% under its all time high of $156.92. Too late or still a buy? Read to the end for my verdict 🟢🔴
💰 Why it's worth a look
• Free cash flow $16.06B over the last 12 months, about 4.5% of the market cap
• Dividend yield about 2.3%
• Q2 free cash flow $4.48B, up 77%
• Market cap about $358B
🚀 What's working
• Q2 sales $16.61B, up 5%. Keytruda $8.4B, up 5%
• Merck and Moderna cancer vaccine plus Keytruda cut melanoma recurrence or death risk by 42% in Phase 3 (Oct 22)
• Europe approved Keytruda plus Padcev for bladder cancer (Oct 21)
• 21 of 31 analysts rate it Buy
• Analyst average target $158.84
😬 What the market fears
• Net loss in Q1 and Q2 2026 from one time deal charges (Cidara $9.0B, Terns $5.7B), so trailing P/E is about 116x
• EV/EBITDA about 21x, not cheap
• Total debt $53.9B, up 52% in a year
• Keytruda, its biggest drug, loses US patent protection in 2028
• A Dutch court blocked the new Keytruda shot in 8 European countries on Oct 7 in a patent fight with Halozyme
• Q3 results due Oct 29
📍 The investment plan
Don't chase it at $145. 2 buys with limit orders, the bigger one lower:
1️⃣ $138 to $141
2️⃣ $124 to $128
Average entry about $131.45.
⛔️ Exit on a weekly close under $119.
🎯 Scenarios from my average entry
Bear $119 break: down 9%
Base $156.92 (all time high): up 19%
Bull $179.66: up 37%
✅ My verdict: BUY on the dip 🟢
Not financial advice
Buy or bye? Tell me 👇
Mohanad Yaman retweeted
In 2013, $TSLA was weeks from running out of cash.
Elon called Larry Page and offered to sell Tesla to $GOOGL for about $6 billion. Page reportedly shook on it 🤝
Then Tesla employees started calling every customer to deliver cars. Sales came back. The deal died.
Tesla today: about $1.47 trillion. Roughly 245x that price.
If you were Elon, would you have taken the $6B?
Buy or Bye? 🤔 $MRK
Merck ran up 77% from its 52 week low of $82.01 and now sits 7% under its all time high of $156.92. Too late or still a buy? Read to the end for my verdict 🟢🔴
💰 Why it's worth a look
• Free cash flow $16.06B over the last 12 months, about 4.5% of the market cap
• Dividend yield about 2.3%
• Q2 free cash flow $4.48B, up 77%
• Market cap about $358B
🚀 What's working
• Q2 sales $16.61B, up 5%. Keytruda $8.4B, up 5%
• Merck and Moderna cancer vaccine plus Keytruda cut melanoma recurrence or death risk by 42% in Phase 3 (Oct 22)
• Europe approved Keytruda plus Padcev for bladder cancer (Oct 21)
• 21 of 31 analysts rate it Buy
• Analyst average target $158.84
😬 What the market fears
• Net loss in Q1 and Q2 2026 from one time deal charges (Cidara $9.0B, Terns $5.7B), so trailing P/E is about 116x
• EV/EBITDA about 21x, not cheap
• Total debt $53.9B, up 52% in a year
• Keytruda, its biggest drug, loses US patent protection in 2028
• A Dutch court blocked the new Keytruda shot in 8 European countries on Oct 7 in a patent fight with Halozyme
• Q3 results due Oct 29
📍 The investment plan
Don't chase it at $145. 2 buys with limit orders, the bigger one lower:
1️⃣ $138 to $141
2️⃣ $124 to $128
Average entry about $131.45.
⛔️ Exit on a weekly close under $119.
🎯 Scenarios from my average entry
Bear $119 break: down 9%
Base $156.92 (all time high): up 19%
Bull $179.66: up 37%
✅ My verdict: BUY on the dip 🟢
Not financial advice
Buy or bye? Tell me 👇
In 2013, $TSLA was weeks from running out of cash.
Elon called Larry Page and offered to sell Tesla to $GOOGL for about $6 billion. Page reportedly shook on it 🤝
Then Tesla employees started calling every customer to deliver cars. Sales came back. The deal died.
Tesla today: about $1.47 trillion. Roughly 245x that price.
If you were Elon, would you have taken the $6B?
24 hours of FinX, top 25 stocks discussed. Full list in the first reply 👇
🥇 $TSLA takes the top spot with 2,226 mentions, up 57%.
Still the most discussed name after the results and the SpaceX talk. Closed around $372.
🚀 Biggest mention spikes:
$BOLT up 1,591%. Completed a reverse merger with Prana Therapies and a $120M private placement. Stock ripped about 50% on the news. Small name, big move.
$CLRO up 920%. Micro-cap spike. No fresh company news in the window. Pure attention and volume.
$MSFT up 103%. Mentions jumped into the week. Earnings Wednesday after the close. Azure and AI spend still the test.
$GOOGL up 97%. Same earnings window. Mentions up with the other hyperscalers.
$IREN up 68%. Still active in the neocloud conversation. $NBIS and $CRWV holding volume too.
Same 24 hours. Earnings week and a couple of small-cap spikes drove the mentions.
Attention is not a signal ⚡
TOP 25 STOCKS by X mentions in the past 24 hours
🥇 $TSLA 2,226 (+56.8%)
🥈 $SPCX 1,736 (+18.1%)
🥉 $IREN 1,465 (+67.6%)
$NVDA 1,386 (+15.6%)
$NBIS 1,276 (+48.7%)
$AMZN 1,056 (+57.6%)
$MSFT 982 (+102.9%)
$GOOGL 956 (+96.7%)
$GME 818 (+94.8%)
$META 780 (+9.4%)
$CRWV 769 (+80.1%)
$MU 757 (+20%)
$CLRO 663 (+920%)
$SOFI 630 (+73.1%)
$ASTS 576 (+16.1%)
$BOLT 575 (+1591.2%)
$HOOD 534 (+79.2%)
$AAPL 494 (+19.3%)
$AMD 471 (+30.8%)
$PLTR 469 (+57.4%)
$AVGO 468 (+51%)
$RKLB 458 (+71.5%)
$AI 406 (+12.5%)
$MSTR 387 (+27.3%)
$CIFR 370 (+54.8%)
All 10 swing setups are up and absolutely free 🙏
Housing, rails, healthcare, software and consumer. Good spots to watch if money keeps rotating out of AI.
I want to find others doing the same. Who shares free swing setups that actually help? Tag them below so we can all support them 🤝
$LEN is breaking out of a descending trendline 👀
Lennar, one of the largest US homebuilders.
🔹 The falling line from the June high capped every rally: $96.03, then $89.65, then $84.24
🔹 Thursday's surge broke through it, and Friday closed at $84.92
🔹 The 200-day near $92 is the next test
📊 FQ3 revenue $8.0B, net earnings $284M ($1.19 per share, $1.23 excluding one-time items), gross margin 15.8% (up from 15.6%)
💰 Record cycle times, $256M of buybacks and $119M of dividends in the quarter
📈 FQ4 guide: deliveries 22,000–23,000 homes at a 15.5–16.0% gross margin
⚠️ FQ3 new orders fell 9% and came in below guidance with mortgage rates back near 7%, and FQ4 orders are guided at 19,500–20,500
✅ Confirm: daily close holds over $84.92
🟢 TP1 $89.07 (+4.9%) • TP2 $95.64 (+12.6%) • TP3 $102.82 (+21.1%)
⛔ Invalid: daily close under $82.87 (−2.4%)
Risk from the Confirm level to Invalid is about 2.4%, and TP1 pays about 2x.
Please respect your SL level 🙏
$QLYS triangle is breaking out 👀
Qualys, cloud-based cybersecurity and compliance software.
🔹 Ascending triangle: higher lows from $149.13 under a lid near $206 from August to October
🔹 Friday broke out on almost double the usual volume and closed at $216.70, a new all-time high
🔹 A daily close that holds over $216.70 confirms it
📊 Q2 revenue $182.2M (+11%), non-GAAP EPS $1.98 vs $1.78 expected, adjusted EBITDA $83.8M (46% margin)
💰 FY26 revenue guide raised to $732–$738M, non-GAAP EPS guide $7.74–$7.88
📈 About 28x this year's EPS guide
⚠️ The stock is up about 122% in six months, and Q3 results are expected Tuesday, Nov 3 after the close
✅ Confirm: daily close holds over $216.70
🟢 TP1 $248.98 (+14.9%) • TP2 $263.37 (+21.5%) • TP3 $276.16 (+27.4%)
⛔ Invalid: daily close under $197.06 (−9.1%)
Risk from the Confirm level to Invalid is about 9.1%, and TP1 pays about 1.6x.
Please respect your SL level 🙏
$LTH triangle is breaking out 👀
Life Time, premium athletic country clubs across the US and Canada.
🔹 Higher lows from $36.52 while sellers kept capping it at $41.73
🔹 Friday closed at $41.93, just over the lid
🔹 The next hurdle is Friday's high at $42.58
📊 Q2 revenue $866.0M (+13.7%) vs about $845M expected, adjusted EBITDA $246.5M (+16.8%) at a 28.5% margin
💰 FY26 guide raised: revenue $3.35–$3.375B, adjusted EBITDA $940–$955M, comparable center revenue +7.9–8.3%
📈 Net debt leverage improved to 1.4x from 1.8x, and S&P and Fitch both upgraded to BB
⚠️ Positive free cash flow depends on a $400M sale-leaseback target ($200M done in Q2), and Q3 results come Thursday, Oct 29 before the open
✅ Confirm: daily close holds over $41.93
🟢 TP1 $43.96 (+4.8%) • TP2 $47.24 (+12.7%) • TP3 $50.16 (+19.6%)
⛔ Invalid: daily close under $41.10 (−2.0%)
Risk from the Confirm level to Invalid is about 2.0%, and TP1 pays about 2.4x.
Please respect your SL level 🙏
$ZTS is breaking out of a triple bottom 👀
Zoetis, the world's largest animal health company: pet and livestock medicines, vaccines and diagnostics.
🔹 Triple bottom: held $71.47 in June, $71.00 in August and $68.77 in October, then ran straight back to the $80.17 neckline
🔹 It cleared the neckline Thursday, and Friday closed at $81.03
🔹 A daily close that holds over $81.03 confirms it
📊 Q2 revenue $2.5B (flat, −1% organic), adjusted EPS $1.87 (+5%) vs $1.85 expected
💰 Livestock revenue +11% globally, companion animal diagnostics +12%, International +6% organic
📈 About 13x this year's adjusted EPS guide
⚠️ FY26 adjusted EPS guide was cut to $6.15–$6.25 from $6.85–$7.00 with US companion animal revenue down 11%, and Q3 results come Thursday, Nov 5 before the open
✅ Confirm: daily close holds over $81.03
🟢 TP1 $89.28 (+10.2%) • TP2 $95.62 (+18.0%) • TP3 $101.96 (+25.8%)
⛔ Invalid: daily close under $79.37 (−2.0%)
Risk from the Confirm level to Invalid is about 2.0%, and TP1 pays about 5.0x.
Please respect your SL level 🙏
$UNP is breaking out and retesting 👀
Union Pacific, one of the largest US freight railroads.
🔹 Based at $268.26 for a month while the falling line from the $314.15 high kept pressing down
🔹 Earnings on Oct 22 pushed it through, and Friday held at $292.87
🔹 A daily close that holds over $292.87 confirms the breakout
📊 Q3 revenue $7.2B (+15%), adjusted EPS $3.53 (+15%) vs $3.47 expected, carloads +6%
💰 Adjusted operating ratio 58.8%, with the core ratio (ex fuel and merger costs) improved 110 bps, and the 2026 outlook of high-single-digit EPS growth affirmed
📈 About 23x trailing adjusted EPS
⚠️ Higher fuel prices cost 140 bps on the operating ratio, and the Norfolk Southern merger is still in Surface Transportation Board review
✅ Confirm: daily close holds over $292.87
🟢 TP1 $306.87 (+4.8%) • TP2 $333.41 (+13.8%) • TP3 $352.53 (+20.4%)
⛔ Invalid: daily close under $284.64 (−2.8%)
Risk from the Confirm level to Invalid is about 2.8%, and TP1 pays about 1.7x.
Please respect your SL level 🙏
Mohanad Yaman retweeted
$BE
50 ma weekly bounce anyone?
Don’t miss. Don’t blink. Don’t cry when we’re back at 300$
$BDX triangle is breaking out 👀
Becton Dickinson, medical technology: medical essentials, connected care, biopharma systems and interventional.
🔹 Higher lows since June's $140.11, with sellers capping it at $194.34
🔹 Friday closed at $198.91, above the lid
🔹 Holding over $195.08 opens the next leg
📊 FQ3 revenue $5.0B (+4.4% FX-neutral), adjusted EPS $3.23 (+4.9%), ahead of company expectations
💰 FY26 adjusted EPS guide raised at the midpoint to $12.62–$12.72, with revenue growth now toward the high end of low single digits
📈 About 16x this year's EPS guide, and year-to-date free cash flow is $1.7B (+44.6%)
⚠️ Adjusted operating margin slipped 130 bps to 24.9% in FQ3, and Q4 results come Thursday, Nov 5 before the open
✅ Confirm: daily close holds over $195.08
🟢 TP1 $211.67 (+6.4%) • TP2 $231.36 (+16.3%) • TP3 $256.40 (+28.9%)
⛔ Invalid: daily close under $192.15 (−3.4%)
Risk from the Confirm level to Invalid is about 1.5%, and TP1 pays about 5.7x.
Please respect your SL level 🙏
